Zimmer Biomet Holdings (ZBH) Payables (2009 - 2026)

Zimmer Biomet Holdings has reported Payables for 18 years, with the latest figure at $361.2 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 19.88% year-over-year to $361.2 million; the trailing twelve-month figure through Mar 2026 stood at $361.2 million (up 19.88% YoY), and the FY2025 full-year result was $303.0 million, up 55.7% from the prior year.
• Payables for Q1 2026 stood at $361.2 million, up from $303.0 million in the prior quarter.
• The five-year high for Payables was $437.1 million in Q4 2022, with the low at $194.6 million in Q4 2024.
• Average Payables over 5 years is $337.7 million, with a median of $333.9 million recorded in 2022.
• Year-over-year, Payables plunged 52.61% in 2024 and surged 55.7% in 2025.
• Tracing ZBH's Payables over 5 years: stood at $437.1 million in 2022, then declined by 6.06% to $410.6 million in 2023, then sank by 52.61% to $194.6 million in 2024, then jumped by 55.7% to $303.0 million in 2025, then rose by 19.21% to $361.2 million in 2026.
• The last three Payables figures came in at $361.2 million (Q1 2026), $303.0 million (Q4 2025), and $315.3 million (Q3 2025), per Business Quant data.

Peer Comparison